their reproductive window was narrower and closes faster
A study from Lagos State University has quietly illuminated a hidden cost of sickle cell anemia: the disease appears to narrow the reproductive window for women who carry it, leaving them with significantly fewer viable eggs than their peers. Researchers comparing 150 women found that those with sickle cell anemia had AMH levels and follicle counts roughly 60% lower than healthy controls — a biological reality that most patients may never be told in time to act upon. The findings do not yet explain the mechanism, but they carry an unmistakable human message: a disease already defined by suffering may also be quietly shaping the futures of the women who live with it.
- Women with sickle cell anemia in the study had median AMH levels of 1.52 ng/mL versus 3.8 in healthy peers — a gap that signals a meaningfully compressed fertility timeline.
- Nearly 79% of women with sickle cell anemia in the sample had never had children, compared to 43% of controls, reflecting both biological limitation and the weight of living with a serious chronic illness.
- Researchers expected oxidative stress to explain the ovarian damage, but the data refused that tidy answer — the mechanism behind the reduced egg supply remains unidentified, deepening the urgency for further investigation.
- Age was the only clear predictor of ovarian reserve decline, meaning the clock runs on the same schedule for all women — but may start from a lower point for those with sickle cell anemia.
- Clinicians are now being called to act on incomplete knowledge: early fertility counseling and egg preservation discussions should begin sooner, even before the full biological picture is understood.
A study from Lagos State University has found that women living with sickle cell anemia face a significant and largely unacknowledged threat to their fertility. Comparing 75 women with the disease to 75 healthy peers — all in their late twenties on average — researchers discovered that those with sickle cell anemia had dramatically lower ovarian reserve, the medical measure of remaining egg supply.
The numbers were stark. Women with sickle cell anemia had a median anti-Mullerian hormone level of 1.52 nanograms per milliliter, compared to 3.8 in the control group. Ultrasound follicle counts averaged 12 versus 15. Both measures told the same story: a narrower reproductive window.
Sickle cell anemia corrupts hemoglobin, causing red blood cells to deform, break apart, and clog small vessels — starving tissues of oxygen and triggering painful crises. Researchers suspected that oxidative stress, an imbalance of harmful molecules the body cannot neutralize, might be damaging the ovaries. But the data surprised them. Although women with sickle cell anemia showed altered oxidative stress markers, these had no measurable connection to their reduced egg supply. The true mechanism remains unidentified. Age was the only clear predictor of decline.
A secondary finding added texture to the picture: nearly 79% of women with sickle cell anemia in the sample had never had children, compared to 43% of controls — a gap shaped by both biological reality and the lived weight of managing a serious chronic illness.
The researchers concluded with a clinical call to action. Women with sickle cell anemia should receive early fertility counseling and be offered preservation options — including egg freezing — while their ovarian reserve is less depleted. The disease, they suggested, may be quietly consuming reproductive time that patients do not yet know they are losing. The study, published in Scientific Reports, opens the door to further investigation into mechanisms that remain, for now, only partly understood.
A study from Lagos State University has found that women living with sickle cell anemia face a significant biological challenge to their fertility: their ovaries contain fewer viable eggs than women without the disease. Researchers compared 75 women with sickle cell anemia to 75 women without it, all in their late twenties on average, and discovered a stark difference in ovarian reserve—the medical term for the remaining supply of eggs available for reproduction.
The numbers tell the story plainly. Women with sickle cell anemia had a median blood level of anti-Mullerian hormone, a key fertility marker, of 1.52 nanograms per milliliter, compared to 3.8 in the control group. When doctors counted the actual follicles visible in the ovaries during ultrasound, women with sickle cell anemia averaged 12, while the comparison group averaged 15. Both measures pointed to the same conclusion: their reproductive window was narrower.
Sickle cell anemia, the most severe form of sickle cell disease, works by corrupting hemoglobin, the protein that carries oxygen in red blood cells. The malformed cells take on a sickle shape, break apart more easily, and can clog small blood vessels, starving tissues of oxygen and triggering agonizing crises. The disease also causes chronic anemia—a persistent shortage of healthy red blood cells. The researchers hypothesized that this combination of factors, along with oxidative stress (an imbalance of harmful molecules the body cannot neutralize), might be damaging the ovaries.
But the study revealed something unexpected. While women with sickle cell anemia did show altered levels of oxidative stress markers—specifically, lower levels of the protective enzyme superoxide dismutase—these changes had no measurable connection to their reduced ovarian reserve. The researchers found no significant link between oxidative stress markers and the egg supply. This suggests that something else about the disease, something not yet identified, is affecting fertility. Age emerged as the only clear predictor: older women with sickle cell anemia had fewer eggs, just as older women in the general population do.
The study also revealed a secondary but telling detail: women with sickle cell anemia in the sample were significantly more likely to be underweight and to have no children. Nearly 79 percent had never had children, compared to 43 percent in the control group. This gap likely reflects both the biological reality of reduced fertility and the practical reality that women facing this diagnosis may delay or forgo attempts at pregnancy.
The researchers emphasized that their findings point toward a clinical imperative. "These results highlight the importance of early fertility counseling and consideration of fertility preservation strategies in women with sickle cell anemia," they wrote. The implication is clear: women diagnosed with this disease should have access to conversations about their reproductive options—including egg freezing or other preservation methods—while they are younger and their ovarian reserve is less depleted. The disease itself may be stealing time they did not know they had to lose.
The study, published in Scientific Reports, opens a door to further investigation. The researchers acknowledged that oxidative stress might still play a role through indirect mechanisms—cumulative tissue damage, interactions with other factors—that their measurements did not capture. But for now, the mechanism remains partly a mystery. What is certain is that women with sickle cell anemia face a reproductive health challenge that deserves earlier, more deliberate clinical attention than it has historically received.
Notable Quotes
These findings suggest that other disease-related factors, beyond the oxidative stress indices measured in this study, may contribute to ovarian dysfunction in sickle cell anemia.— Study researchers, Lagos State University
Our results highlight the importance of early fertility counseling and consideration of fertility preservation strategies in women with sickle cell anemia.— Study researchers, Lagos State University
The Hearth Conversation Another angle on the story
Why does sickle cell anemia specifically damage the ovaries? Is it the same mechanism that causes pain crises?
That's the puzzle the study couldn't fully solve. The disease damages ovaries through chronic anemia and blocked blood vessels, but the oxidative stress markers they measured didn't correlate with the egg loss. It's like finding the crime scene but not the weapon.
So what could be happening instead?
The researchers suspect other disease-related factors—maybe cumulative tissue damage over years, or interactions between multiple systems they didn't measure. The ovaries might be suffering in ways that don't show up in the specific markers they tested.
Does this mean women with sickle cell anemia can't have children?
No. The study shows reduced ovarian reserve, not infertility. But it means their window is narrower and closes faster. A woman might have fewer eggs and less time to use them before age makes the problem worse.
Why is early counseling so important then?
Because if a woman wants biological children, she needs to know this about herself before she's 35 or 40. Egg freezing, adoption, other options—these conversations need to happen when she's young enough for them to actually work.
The study found women with sickle cell anemia were mostly childless. Is that because they can't have children, or because they chose not to?
Probably both. Some may have faced infertility. Others may have decided the disease made pregnancy too risky or difficult. The study doesn't separate those stories, but the gap is real: 79 percent childless versus 43 percent in the comparison group.
What happens next? Does this change how doctors treat women with sickle cell anemia?
It should. Right now, fertility isn't always part of the conversation. This study is saying it needs to be—early, routinely, and with real options on the table.